First FDA cleared non-drug treatment for generalized anxiety disorder. Clearance is the second FDA-clearance for Big Health.

Big Health has appointed a new CEO, Yael Berman, to lead us through our next phase of growth.

While the COVID public health emergency may have ended, the global mental health crisis certainly has not. Our global health systems’ capacity to meet mental health needs is more strained than ever. Data just released by the American Psychological Association (APA) show that patients are presenting with more severe mental health symptoms, wait times are growing significantly, and access to care is shrinking.

While the COVID public health emergency may have ended, the global mental health crisis certainly has not.